Sichenzia Ross Ference LLP Represents H.C. Wainwright in $6 Million At-The-Market Offering of Sonoma Pharmaceuticals, Inc.

Press Release – New York, NY – August 2, 2021 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC as sales agent in a $6 million At-The-Market Offering (“ATM”) of Sonoma Pharmaceuticals, Inc. (NASDAQ: “SNOA”) common stock.
The shares were registered on SNOA’s registration statement on Form S-3 (File No. 333-250925), which was declared effective by the SEC on December 22, 2020, and prospectus supplement relating to the ATM filed with the Securities and Exchange Commission on July 30, 2021.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, Avital Perlman and Jeff Cahlon and associates Matthew Siracusa and Mayank Pradhan.
- Sichenzia Ross Ference Carmel LLP Represents CIMG Inc. in $10 Million Private Placement Offering - February 14, 2025
- Sichenzia Ross Ference Carmel LLP Represents Dominari Securities, LLC and Revere Securities LLC in $15 Million Initial Public Offering of Shares of Common Stock of Aureus Greenway Holdings Inc. - February 13, 2025
- Sichenzia Ross Ference Carmel LLP Represents Autozi Internet Technology (Global) Ltd. in Private Placement Offering - February 13, 2025